vs
Side-by-side financial comparison of agilon health, inc. (AGL) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.
Molson Coors Beverage Company is the larger business by last-quarter revenue ($2.7B vs $1.4B, roughly 1.9× agilon health, inc.). Molson Coors Beverage Company runs the higher net margin — 5.5% vs 0.0%, a 5.5% gap on every dollar of revenue. On growth, Molson Coors Beverage Company posted the faster year-over-year revenue change (2.0% vs -3.0%). Over the past eight quarters, agilon health, inc.'s revenue compounded faster (-2.1% CAGR vs -15.8%).
agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.
Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.
AGL vs TAP — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $2.7B |
| Net Profit | $49.0K | $150.1M |
| Gross Margin | — | 33.0% |
| Operating Margin | — | — |
| Net Margin | 0.0% | 5.5% |
| Revenue YoY | -3.0% | 2.0% |
| Net Profit YoY | — | 25.0% |
| EPS (diluted) | — | $0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | $2.7B | ||
| Q4 25 | $1.6B | $3.1B | ||
| Q3 25 | $1.4B | $3.5B | ||
| Q2 25 | $1.4B | $3.7B | ||
| Q1 25 | $1.5B | $2.7B | ||
| Q4 24 | $1.5B | $3.2B | ||
| Q3 24 | $1.5B | $3.6B | ||
| Q2 24 | $1.5B | $3.8B |
| Q1 26 | $49.0K | $150.1M | ||
| Q4 25 | $-188.9M | $238.3M | ||
| Q3 25 | $-110.2M | $-2.9B | ||
| Q2 25 | $-104.4M | $428.7M | ||
| Q1 25 | $12.1M | $121.0M | ||
| Q4 24 | $-105.8M | $287.8M | ||
| Q3 24 | $-117.6M | $199.8M | ||
| Q2 24 | $-30.7M | $427.0M |
| Q1 26 | — | 33.0% | ||
| Q4 25 | — | 31.0% | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 34.3% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | — | 32.0% | ||
| Q3 24 | — | 33.4% | ||
| Q2 24 | — | 34.6% |
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 10.4% | ||
| Q3 25 | -9.1% | -98.5% | ||
| Q2 25 | -8.3% | 15.6% | ||
| Q1 25 | -1.4% | 6.9% | ||
| Q4 24 | -7.1% | 12.0% | ||
| Q3 24 | -9.2% | 12.5% | ||
| Q2 24 | -2.9% | 15.6% |
| Q1 26 | 0.0% | 5.5% | ||
| Q4 25 | -12.0% | 7.6% | ||
| Q3 25 | -7.7% | -84.0% | ||
| Q2 25 | -7.5% | 11.5% | ||
| Q1 25 | 0.8% | 4.5% | ||
| Q4 24 | -6.9% | 8.9% | ||
| Q3 24 | -8.1% | 5.5% | ||
| Q2 24 | -2.1% | 11.1% |
| Q1 26 | — | $0.80 | ||
| Q4 25 | — | $1.32 | ||
| Q3 25 | — | $-14.79 | ||
| Q2 25 | — | $2.13 | ||
| Q1 25 | — | $0.59 | ||
| Q4 24 | — | $1.39 | ||
| Q3 24 | — | $0.96 | ||
| Q2 24 | — | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $140.0M | $382.6M |
| Total DebtLower is stronger | $15.3M | $3.8B |
| Stockholders' EquityBook value | — | $10.3B |
| Total Assets | $1.5B | $22.4B |
| Debt / EquityLower = less leverage | — | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $140.0M | $382.6M | ||
| Q4 25 | $173.7M | $896.5M | ||
| Q3 25 | $171.7M | $950.2M | ||
| Q2 25 | $171.4M | $613.8M | ||
| Q1 25 | $136.9M | $412.7M | ||
| Q4 24 | $188.2M | $969.3M | ||
| Q3 24 | $148.2M | $1.0B | ||
| Q2 24 | $109.5M | $1.6B |
| Q1 26 | $15.3M | $3.8B | ||
| Q4 25 | $35.0M | $6.3B | ||
| Q3 25 | — | $6.3B | ||
| Q2 25 | — | $6.3B | ||
| Q1 25 | — | $6.2B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | — | $6.2B | ||
| Q2 24 | — | $7.0B |
| Q1 26 | — | $10.3B | ||
| Q4 25 | $126.7M | $10.2B | ||
| Q3 25 | $306.1M | $10.3B | ||
| Q2 25 | $408.9M | $13.4B | ||
| Q1 25 | $500.3M | $13.1B | ||
| Q4 24 | $471.0M | $13.1B | ||
| Q3 24 | $574.9M | $13.3B | ||
| Q2 24 | $676.6M | $13.2B |
| Q1 26 | $1.5B | $22.4B | ||
| Q4 25 | $1.3B | $22.7B | ||
| Q3 25 | $1.6B | $22.9B | ||
| Q2 25 | $1.7B | $26.8B | ||
| Q1 25 | $1.9B | $25.9B | ||
| Q4 24 | $1.7B | $26.1B | ||
| Q3 24 | $2.1B | $26.6B | ||
| Q2 24 | $2.2B | $27.4B |
| Q1 26 | — | 0.38× | ||
| Q4 25 | 0.28× | 0.61× | ||
| Q3 25 | — | 0.61× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
